Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Lifestyle Modifications for Preventing and Treating Heart Failure
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure)
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y

Original Research

Volume 72, Issue 19, November 2018

JOURNAL：J Am Coll Cardiol.

Lifestyle Modifications for Preventing and Treating Heart Failure

M Aggarwal, B Bozkurt, on behalf of American College of Cardiology’s Nutrition and Lifestyle Committee of the Prevention of Cardiovascular Disease Council.

4955

Keywords: heart failure prevention; lifestyle modification; outcome

FULL TEXT PDF